Women need to be fully informed about risks of hormone replacement therapy.
作者信息
Price E H, Little H K
出版信息
BMJ. 1996 May 18;312(7041):1301. doi: 10.1136/bmj.312.7041.1301.
Abstract
摘要
相似文献
1
Women need to be fully informed about risks of hormone replacement therapy.需要让女性充分了解激素替代疗法的风险。
BMJ. 1996 May 18;312(7041):1301. doi: 10.1136/bmj.312.7041.1301.
2
Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.激素替代疗法的争议。绝经后女性中激素替代疗法作为乳腺癌的一个风险因素。
Acta Pol Pharm. 2005 May-Jun;62(3):241-7.
3
Benefits and risks of hormone/estrogen replacement.
Nurs Clin North Am. 1996 Dec;31(4):815-25.
4
[Should patients be informed of potential but not confirmed risks of cancer linked to menopausal hormone replacement treatment?].[是否应告知患者与绝经激素替代治疗相关的潜在但未确诊的癌症风险？]
Contracept Fertil Sex. 1996 Mar;24(3):184-7.
5
Thoughts around the ridges.围绕着山脊的想法。
Aust Fam Physician. 1996 Oct;25(10):1643-4.
6
Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
J Womens Health. 1999 Apr;8(3):347-57. doi: 10.1089/jwh.1999.8.347.
7
Postmenopausal hormone therapy: cardiovascular risks.绝经后激素治疗：心血管风险
Prescrire Int. 2003 Apr;12(64):65-9.
8
[Postmenopausal hormone replacement therapy and breast cancer risk: an update].[绝经后激素替代疗法与乳腺癌风险：最新进展]
Rev Med Liege. 2003 Apr;58(4):254-60.
9
A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.雌激素替代疗法对乳腺癌风险影响的荟萃分析。
JAMA. 1991 Apr 17;265(15):1985-90.
10
Estrogen replacement: are the benefits worth the risks?雌激素替代疗法：益处是否值得冒风险？
Hosp Pract (1995). 1997 Apr 15;32(4):67-8. doi: 10.1080/21548331.1997.11443464.
引用本文的文献
1
Hormone replacement therapy for all? Long-term randomised controlled trial is needed.全民激素替代疗法？需要进行长期随机对照试验。
BMJ. 1996 Nov 9;313(7066):1206. doi: 10.1136/bmj.313.7066.1206.
2
Use of hormone replacement therapy. Authors gave distorted view through selective citation.激素替代疗法的使用。作者通过选择性引用给出了扭曲的观点。
BMJ. 1996 Sep 14;313(7058):686-7. doi: 10.1136/bmj.313.7058.686b.
3
Use of hormone replacement therapy. May depend on whether the menopause is regarded as physiological or pathological.激素替代疗法的使用。可能取决于绝经被视为生理性还是病理性。
BMJ. 1996 Sep 14;313(7058):686. doi: 10.1136/bmj.313.7058.686a.
4
Use of hormone replacement therapy. Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive.激素替代疗法的使用。与激素替代疗法相关的乳腺癌风险证据仍不确凿。
BMJ. 1996 Sep 14;313(7058):686. doi: 10.1136/bmj.313.7058.686.
本文引用的文献
1
Utilisation of hormone replacement therapy by women doctors.女医生对激素替代疗法的使用情况。
BMJ. 1995 Nov 25;311(7017):1399-401. doi: 10.1136/bmj.311.7017.1399.
2
Breast cancer and hormonal supplements in postmenopausal women.绝经后女性的乳腺癌与激素补充剂
BMJ. 1995 Sep 16;311(7007):699-700. doi: 10.1136/bmj.311.7007.699.
3
Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.一组长期使用激素替代疗法人群的死亡率：最新分析
Br J Obstet Gynaecol. 1990 Dec;97(12):1080-6. doi: 10.1111/j.1471-0528.1990.tb02494.x.
4
Postmenopausal oestrogen and cardioprotection.绝经后雌激素与心脏保护作用
Lancet. 1991 Apr 6;337(8745):833-4. doi: 10.1016/0140-6736(91)92526-8.
Zotero 插件